v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ Deficit - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024   $ 719 [1] $ 24,281 $ (74,235) $ (49,235)
Balance (in Shares) at Dec. 31, 2024 [1]   7,187,500      
Net Income (Loss)   [1] (525) (525)
Balance at Mar. 31, 2025   $ 719 [1] 24,281 (74,760) (49,760)
Balance (in Shares) at Mar. 31, 2025 [1]   7,187,500      
Balance at Dec. 31, 2024   $ 719 [1] 24,281 (74,235) (49,235)
Balance (in Shares) at Dec. 31, 2024 [1]   7,187,500      
Net Income (Loss)         (1,953)
Balance at Jun. 30, 2025   $ 719 [1] 24,281 (76,188) (51,188)
Balance (in Shares) at Jun. 30, 2025 [1]   7,187,500      
Balance at Mar. 31, 2025   $ 719 [1] 24,281 (74,760) (49,760)
Balance (in Shares) at Mar. 31, 2025 [1]   7,187,500      
Net Income (Loss)   [1] (1,428) (1,428)
Balance at Jun. 30, 2025   $ 719 [1] 24,281 (76,188) (51,188)
Balance (in Shares) at Jun. 30, 2025 [1]   7,187,500      
Balance at Dec. 31, 2025 $ 719 (17,415,041) (17,414,322)
Balance (in Shares) at Dec. 31, 2025 7,187,500      
Accretion of Class A Ordinary Shares to redemption amount (2,498,253) (2,498,253)
Net Income (Loss) 2,208,515 2,208,515
Balance at Mar. 31, 2026 $ 719 (17,704,779) (17,704,060)
Balance (in Shares) at Mar. 31, 2026 7,187,500      
Balance at Dec. 31, 2025 $ 719 (17,415,041) (17,414,322)
Balance (in Shares) at Dec. 31, 2025 7,187,500      
Net Income (Loss)         4,458,467
Balance at Jun. 30, 2026 $ 719 (18,068,227) (18,067,508)
Balance (in Shares) at Jun. 30, 2026 7,187,500      
Balance at Mar. 31, 2026 $ 719 (17,704,779) (17,704,060)
Balance (in Shares) at Mar. 31, 2026 7,187,500      
Accretion of Class A Ordinary Shares to redemption amount (2,613,400) (2,613,400)
Net Income (Loss) 2,249,952 2,249,952
Balance at Jun. 30, 2026 $ 719 $ (18,068,227) $ (18,067,508)
Balance (in Shares) at Jun. 30, 2026 7,187,500      
[1] Includes up to 937,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). On November 14, 2025, the Company consummated its Initial Public Offering and sold 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriter’s option to purchase additional Units to cover the over-allotment. As such, the 937,500 shares of Class B ordinary shares were no longer subject to forfeiture.